Assessment of Nutritional Status After Gastric Bypass Surgery

July 2, 2013 updated by: Luc Tappy, MD, University of Lausanne

Assessment of Nutritional Status and Vitamin Deficiencies in Obese Subjects After Gastric Bypass Surgery

This study is aimed at assessing how Roux-en-Y gastric bypass (RYGP) impacts on energy and nutrients' intake, energy expenditure, and nutritional status in obese patients. It will try quantitate energy and protein balance after RYGP, and to identify how RYGP effects the intake of various common dietary protein sources 16 female patients with BMI > 40 kg/m2 and on a waiting list for bariatric surgery will be included. The following measurements will be performed before, and 1, 3, 6, 12, and 36 months after RYGP

  • body weight
  • body composition (bio impedancemetry)
  • basal metabolic rate (open circuit indirect calorimetry)
  • 24-hour urinary urea excretion
  • fasting blood chemistry
  • energy and macronutrient's intake (3-day dietary recall)

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

16

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lausanne, Switzerland, CH-1011
        • Clinical Research Centre, CHUV

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

16 female obese subjects on a waiting list for gastric bypass bariatric surgery

Description

Inclusion Criteria:

  • age 18-65 years
  • gender: females
  • body mass index >35 kg/m2

Exclusion Criteria:

  • GI tract diseases
  • endocrine diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
obese female subjects
16 obese female subjects with BMI > 40 kg/m2 on a waiting list for bariatric surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes in daily dietary protein intake
Time Frame: measurements obtained baseline , and 1,3, 6, 12, 36 months after surgery
changes in 24-hour protein intake will be evaluated by 7-day food diary; portion size will be assessed with the use of photographs from the SU.VI.MAX study
measurements obtained baseline , and 1,3, 6, 12, 36 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes in total energy intake
Time Frame: measurements obtained baseline , and 1,3, 6, 12, 36 months after surgery
changes in 24-hour energy intake will be evaluated by 7-day food diary; portion size will be assessed with the use of photographs from the SU.VI.MAX study
measurements obtained baseline , and 1,3, 6, 12, 36 months after surgery
changes in basal metabolic rate
Time Frame: measurements obtained baseline , and 3, 6, 12, 36 months after surgery
BMR will be measured by indirect calorimetry over a 45-90 min period
measurements obtained baseline , and 3, 6, 12, 36 months after surgery
changes in total energy intake
Time Frame: measurements obtained baseline , and 1,3, 6, 12, 36 months after surgery
Changes in daily total energy intake will be evaluated by 7-day food diary; portion size will be assessed with the use of photographs from the SU.VI.MAX study
measurements obtained baseline , and 1,3, 6, 12, 36 months after surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes in fasting, resting respiratory exchange ratio
Time Frame: measurements obtained baseline, and 3, 6, 12, and 36 months after RYGP
measurement will be obtained by indirect calorimetry
measurements obtained baseline, and 3, 6, 12, and 36 months after RYGP
changes in 24-hour urinary urea excretion
Time Frame: Measurements obtained baseline , and 3, 6, 12, 36 months after RYGP
24-hour urine collections
Measurements obtained baseline , and 3, 6, 12, 36 months after RYGP

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Vittorio Giusti, MD, CHUV

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2008

Primary Completion (Actual)

December 1, 2011

Study Completion (Actual)

December 1, 2011

Study Registration Dates

First Submitted

June 17, 2013

First Submitted That Met QC Criteria

July 2, 2013

First Posted (Estimate)

July 3, 2013

Study Record Updates

Last Update Posted (Estimate)

July 3, 2013

Last Update Submitted That Met QC Criteria

July 2, 2013

Last Verified

June 1, 2013

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 39/08

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Roux-en-Y gastric bypass (RYGP)

3
Subscribe